Investment Summary |
|
---|---|
Date | 2020-04-21 |
Target | Athletics and Health Solutions |
Sector | Healthcare Services |
Investor(s) | Medivolve |
Deal Type | Stake Purchase |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2005 |
Sector | Healthcare Services |
Employees | 25 |
Revenue | 1M CAD (2023) |
Medivolve focuses on commercializing technologies to help combat the COVID-19 pandemic. This includes providing convenient and accessible medical services for testing, prevention, and treatment. Medivolve was incorporated in 2005 and is headquartered in Toronto, Ontario.
DEAL STATS | # |
---|---|
Overall | 2 of 5 |
Sector (Healthcare Services) | 1 of 2 |
Type (Stake Purchase) | 2 of 3 |
State (Ontario) | 1 of 2 |
Country (Canada) | 1 of 2 |
Year (2020) | 2 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-04-13 |
Amino Therapeutics
Cambridge, Massachusetts, United States Amino Therapeutics is working to create the next generation of novel cell-penetrating peptides to spearhead the development of biologic pharmaceuticals focusing on intracellular mechanisms of action. Amino’s current leading project is to develop broad-spectrum protease inhibitors as a potential therapeutic treatment for patients with COVID-19. Amino Therapeutics was formed in Cambridge, Massachusetts. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-06-15 |
Glenco Medical
Ontario, Canada Glenco Medical Corp. is an injury treatment company providing effective and non-invasive remedies to alleviate musculoskeletal and inflammatory pain using wearable therapeutic technologies. Glenco Medical acts as the exclusive Canadian distributor of CareWear wearable therapeutics class II low-level light therapy device. Glenco Medical has extensive experience and orthopedic knowledge from treating sports injuries and garnering expertise establishing successful clinical operations, therapy protocols, and outcome-based practices. |
Buy | - |